- Home
- SSL vs VCEL Comparison
SSL vs VCEL Comparison
Compare SSL & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- VCEL
- Stock Information
- Founded
- SSL 1950
- VCEL 1989
- Country
- SSL South Africa
- VCEL United States
- Employees
- SSL N/A
- VCEL N/A
- Industry
- SSL Oil & Gas Production
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSL Energy
- VCEL Health Care
- Exchange
- SSL Nasdaq
- VCEL Nasdaq
- Market Cap
- SSL 2.3B
- VCEL 2.1B
- IPO Year
- SSL N/A
- VCEL 1997
- Fundamental
- Price
- SSL $5.21
- VCEL $42.29
- Analyst Decision
- SSL
- VCEL Strong Buy
- Analyst Count
- SSL 0
- VCEL 8
- Target Price
- SSL N/A
- VCEL $62.00
- AVG Volume (30 Days)
- SSL 1.3M
- VCEL 431.2K
- Earning Date
- SSL 01-01-0001
- VCEL 07-31-2025
- Dividend Yield
- SSL N/A
- VCEL N/A
- EPS Growth
- SSL N/A
- VCEL 521.85
- EPS
- SSL N/A
- VCEL 0.05
- Revenue
- SSL $13,819,021,376.00
- VCEL $238,541,000.00
- Revenue This Year
- SSL N/A
- VCEL $23.03
- Revenue Next Year
- SSL $2.76
- VCEL $24.52
- P/E Ratio
- SSL N/A
- VCEL $818.49
- Revenue Growth
- SSL N/A
- VCEL 14.80
- 52 Week Low
- SSL $2.78
- VCEL $37.39
- 52 Week High
- SSL $8.40
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- SSL 64.06
- VCEL 49.21
- Support Level
- SSL $5.19
- VCEL $40.41
- Resistance Level
- SSL $5.52
- VCEL $42.49
- Average True Range (ATR)
- SSL 0.13
- VCEL 1.67
- MACD
- SSL 0.03
- VCEL -0.15
- Stochastic Oscillator
- SSL 69.90
- VCEL 43.76
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main segments: Energy business and Chemical business. It generates maximum revenue from the Chemicals segment. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Sasol markets commodity and performance chemicals, sells liquid fuel products, and markets, distributes and transports pipeline gas. Geographically the company generates the majority of its revenue from South Africa.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.